K042594 is an FDA 510(k) clearance for the VANGUARD REPROCESSED NON-ELECTRIC BIOPSY FORCEPS. Classified as Forceps, Biopsy, Non-electric, Reprocessed (product code NON), Class I - General Controls.
Submitted by Vanguard Medical Concepts, Inc. (Lakeland, US). The FDA issued a Cleared decision on January 25, 2005 after a review of 124 days - within the typical 510(k) review window.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.
View all Vanguard Medical Concepts, Inc. devices